GlobalData supported a top pharmaceutical company understand the competitive digital Landscapes for HCV in 8 Major Markets.
The client wanted to understand the digital marketing landscapes for Hepatitis C in 8 markets (US, EU5, Japan & Australia) detailing branded and unbranded digital initiatives targeting patients & healthcare practitioners (HCPs).
Our Solution
GlobalData assisted the client by creating comprehensive digital landscapes for the disease in each of the major markets by providing an analysis of various types of initiatives including benchmarking of features and channel strength of websites in addition to the analysis of social media and mobile applications for patients and physicians apart from clinical conference coverage and analysis of advertisements and publishers.
Outcome
GlobalData provided clear and actionable recommendations on digital strategies to help the client:
- Track key competitor activity across the entire digital landscape
- Compare performance of digital activities across channels
- Identify best practice examples of pre- & post-launch digital activities
- Determine ‘must-have’ digital assets for patient & HCP engagement in specific diseases
Our consultants work closely with you to understand requirements and develop a tailored approach and deliverables.
